Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: Toward mitochondria-targeted clinical strategies

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Pagano, Giovanni ^a   Aiello Talamanca, Annarita ^a   Castello, Giuseppe ^a   Cordero, Mario D ^b   D'Ischia, Marco ^c   Gadaleta, Maria Nicola ^d   Pallardó, Federico V ^e   Petrović, Sandra ^f   Tiano, Luca ^g   Zatterale, Adriana ^h  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF SEVILLE   (Spain)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d CNR   (Italy)

^e UNIVERSITY OF VALENCIA   (Spain)

^f UNIVERSITY OF BELGRADE   (Serbia)

^g UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^h ASL Napoli 1   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PATHOLOGY;

CHEMOPREVENTION; MITOCHONDRIAL DAMAGE; MITOCHONDRIAL DISEASE; MITOCHONDRIAL DYSFUNCTION; PROOXIDANT;

MITOCHONDRIA;

ANTIOXIDANT;

AGING; AUTOIMMUNE DISEASE; CANCER SUSCEPTIBILITY; CHEMOPROPHYLAXIS; COCKAYNE SYNDROME; CYTOSOL; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENETIC DISORDER; HUMAN; MENTAL DISEASE; MITOCHONDRIAL DYSFUNCTION; MITOCHONDRION; MUSCLE DISEASE; NEOPLASM; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; REVIEW; SKIN DISEASE; METABOLISM; PATHOLOGY; ULTRASTRUCTURE;

AGING; AUTOIMMUNE DISEASES; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NEOPLASMS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 84901933198     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/541230     Document Type: Review

References (314)

1. Vitols E., Linnane A. W., Studies on the oxidative metabolism of Saccharomyces cerevisiae. II. Morphology and oxidative phosphorylation capacity of mitochondria and derived particles from baker's yeast. The Journal of Biophysical and Biochemical Cytology 1961 9 701 710 2-s2.0-78651125215
2. Bellamy D., The endogenous citric acid-cycle intermediates and amino acids of. The Biochemical Journal 1962 82 218 224 2-s2.0-78651120410
3. 2+ homeostasis, cell death, proliferation and differentiation. Chemico-Biological Interactions 1991 77 1 1 23 2-s2.0-0025960006 10.1016/0009-2797(91)90002-O
4. Sohal R. S., Brunk U. T., Mitochondrial production of pro-oxidants and cellular senescence. Mutation Research-DNAging Genetic Instability and Aging 1992 275 3-6 295 304 2-s2.0-0026673472 10.1016/0921-8734(92)90033-L
5. Piccolo G., Banfi P., Azan G., Rizzuto R., Bisson R., Sandona D., Bellomo G., Biological markers of oxidative stress in mitochondrial myopathies with progressive external ophthalmoplegia. The Journal of the Neurological Sciences 1991 105 1 57 60 2-s2.0-0025878889 10.1016/0022-510X(91)90118-Q
6. Di Monte D. A., Chan P., Sandy M. S., Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage? Annals of Neurology 1992 32 supplement S111 S115 2-s2.0-0026694525
7. Chinnery P. F., Pagon R. A., Bird T. D., Dolan C. R., Mitochondrial disorders overview. Synonyms: mitochondrial encephalomyopathies, mitochondrial myopathies, oxidative phosphorylation disorders, respiratory chain disorders. GeneReviews 2010 Seattle, Wash, USA University of Washington 1993 2013. http://www.ncbi.nlm.nih.gov/books/NBK1116/
8. Schon E. A., di Mauro S., Hirano M., Human mitochondrial DNA: roles of inherited and somatic mutations. Nature Reviews Genetics 2012 13 12 878 890
9. Carelli V., La Morgia C., Valentino M. L., Rizzo G., Carbonelli M., de Negri A. M., Sadun F., Carta A., Guerriero S., Simonelli F., Sadun A. A., Aggarwal D., Liguori R., Avoni P., Baruzzi A., Zeviani M., Montagna P., Barboni P., Idebenone treatment in Leber's hereditary optic neuropathy. Brain 2011 134 part 9 e188 2-s2.0-80555157755
10. Kumar M., Kaur P., Kumar M., Clinical characterization and mitochondrial DNA sequence variations in Leber hereditary optic neuropathy. Molecular Vision 2012 18 2687 2699
11. Sadun A. A., Chicani C. F., Ross-Cisneros F. N., Barboni P., Thoolen M., Shrader W. D., Kubis K., Carelli V., Miller G., Effect of EPI-743 on the clinical course of the mitochondrial disease leber hereditary optic neuropathy. Archives of Neurology 2012 69 3 331 338 2-s2.0-84858599179 10.1001/archneurol. 2011.2972
12. Martinelli D., Catteruccia M., Piemonte F., EPI-743 reverses the progression of the pediatric mitochondrial disease-genetically defined Leigh Syndrome. Molecular Genetics and Metabolism 2012 107 3 383 388
13. Lebiedzinska M., Karkucinska-Wieckowska A., Wojtala A., Disrupted ATP synthase activity and mitochondrial hyperpolarisation-dependent oxidative stress is associated with p66Shc phosphorylation in fibroblasts of NARP patients. International Journal of Biochemistry and Cell Biology 2013 45 1 141 150
14. Mattiazzi M., Vijayvergiya C., Gajewski C. D., DeVivo D. C., Lenaz G., Wiedmann M., Manfredi G., The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Human Molecular Genetics 2004 13 8 869 879 2-s2.0-1942453308 10.1093/hmg/ddh103 (Pubitemid 38515215)
15. Ihara Y., Kibata M., Hayabara T., Katayama S., Konishi H., Miura K., Kohno M., Kawai M., Yokoi I., Mori A., Free radicals in the cerebrospinal fluid are associated with neurological disorders including mitochondrial encephalomyopathy. Biochemistry and Molecular Biology International 1997 42 5 937 947 2-s2.0-0031398305 (Pubitemid 28297585)
16. Vattemi G., Mechref Y., Marini M., Tonin P., Minuz P., Grigoli L., Guglielmi V., Klouckova I., Chiamulera C., Meneguzzi A., Di Chio M., Tedesco V., Lovato L., Degan M., Arcaro G., Lechi A., Novotny M. V., Tomelleri G., Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement. Molecular and Cellular Proteomics 2011 10 4 M110.002964 2-s2.0-79953322206 10.1074/mcp.M110.002964
17. Tan T. M. M., Caputo C., Medici F., Pambakian A. L., Dornhorst A., Meeran K., Williams G. R., Khoo B., MELAS syndrome, diabetes and thyroid disease: the role of mitochondrial oxidative stress. Clinical Endocrinology 2009 70 2 340 341 2-s2.0-58549108191 10.1111/j.1365-2265.2008.03341.x
18. Cotán D., Cordero M. D., Garrido-Maraver J., Oropesa-Ávila M., Rodríguez-Hernández Á., Gómez Izquierdo L., de La Mata M., de Miguel M., Bautista Lorite J., Rivas Infante E., Jackson S., Navas P., Sánchez-Alcázar J. A., Secondary coenzyme Q(10) deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. The FASEB Journal 2011 25 8 2669 2687 2-s2.0-80051675804 10.1096/fj.10-165340
19. Katayama Y., Maeda K., Iizuka T., Hayashi M., Hashizume Y., Sanada M., Kawai H., Kashiwagi A., Accumulation of oxidative stress around the stroke-like lesions of MELAS patients. Mitochondrion 2009 9 5 306 313 2-s2.0-70149105914 10.1016/j.mito.2009.04.002
20. Ma Y., Chen Y., Lu C., Liu C., Wei Y., Upregulation of matrix metalloproteinase 1 and disruption of mitochondrial network in skin fibroblasts of patients with MERRF syndrome. Annals of the New York Academy of Sciences 2005 1042 55 63 2-s2.0-22044452993 10.1196/annals.1338.006 (Pubitemid 40967621)
21. Wu S., Ma Y., Wu Y., Chen Y., Wei Y., Mitochondrial DNA mutation-elicited oxidative stress, oxidative damage, and altered gene expression in cultured cells of patients with MERRF syndrome. Molecular Neurobiology 2010 41 2-3 256 266 2-s2.0-77955089549 10.1007/s12035-010-8123-7
22. Salles J. E., Moisés V. A., Almeida D. R., Chacra A. R., Moisés R. S., Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10. Diabetes Research and Clinical Practice 2006 72 1 100 103 2-s2.0-33645326875 10.1016/j.diabres.2005.09.005
23. Lax N. Z., Campbell G. R., Reeve A. K., Ohno N., Zambonin J., Blakely E. L., Taylor R. W., Bonilla E., Tanji K., DiMauro S., Jaros E., Lassmann H., Turnbull D. M., Mahad D. J., Loss of myelin-associated glycoprotein in kearns-sayre syndrome. Archives of Neurology 2012 69 4 490 499 2-s2.0-84859999840 10.1001/archneurol.2011.2167
24. Mancuso M., Orsucci D., Calsolaro V., Logerfo A., Allegrini L., Petrozzi L., Simoncini C., Rocchi A., Trivella F., Murri L., Siciliano G., Tetracycline treatment in patients with progressive external ophthalmoplegia. Acta Neurologica Scandinavica 2011 124 6 417 423 2-s2.0-80054951967 10.1111/j.1600-0404.2011.01536.x
25. Wolf J., Obermaier-Kusser B., Jacobs M., Milles C., Mörl M., Von Pein H. D., Grau A. J., Bauer M. F., A new mitochondrial point mutation in the transfer RNALys gene associated with progressive external ophthalmoplegia with impaired respiratory regulation. The Journal of the Neurological Sciences 2012 316 1-2 108 111 2-s2.0-84859443887 10.1016/j.jns.2012.01.013
26. Manea E. M., Leverger G., Bellmann F., Stanescu P. A., Mircea A., Lèbre A., Rötig A., Munnich A., Pearson syndrome in the neonatal period: two case reports and review of the literature. Journal of Pediatric Hematology/Oncology 2009 31 12 947 951 2-s2.0-73949119072 10.1097/MPH. 0b013e3181bbc4ef
27. Kefala-Agoropoulou K., Roilides E., Lazaridou A., Karatza E., Farmaki E., Tsantali H., Augoustides-Savvopoulou P., Tsiouris J., Pearson syndrome in an infant heterozygous for C282Y allele of HFE gene. Hematology 2007 12 6 549 553 2-s2.0-35748951618 10.1080/10245330701400900 (Pubitemid 350048066)
28. Uusimaa J., Finnilä S., Vainionpää L., Kärppä M., Herva R., Rantala H., Hassinen I. E., Majamaa K., A mutation in mitochondrial DNA-encoded cytochrome c oxidase II gene in a child with Alpers-Huttenlocher-like disease. Pediatrics 2003 111 3 e262 e268 2-s2.0-0038621826
29. de Vries M. C., Rodenburg R. J., Morava E., van Kaauwen E. P. M., ter Laak H., Mullaart R. A., Snoeck I. N., van Hasselt P. M., Harding P., van den Heuvel L. P. W., Smeitink J. A. M., Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations. European Journal of Pediatrics 2007 166 3 229 234 2-s2.0-33847612847 10.1007/s00431-006-0234-9 (Pubitemid 46352514)
30. Lewis W., Day B. J., Kohler J. J., Hosseini S. H., Chan S. S. L., Green E. C., Haase C. P., Keebaugh E. S., Long R., Ludaway T., Russ R., Steltzer J., Tioleco N., Santoianni R., Copeland W. C., Decreased mtDNA, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase γ Laboratory Investigation 2007 87 4 326 335 2-s2.0-33947537266 10.1038/labinvest.3700523 (Pubitemid 46474566)
31. Saneto R. P., Cohen B. H., Copeland W. C., Alpers-Huttenlocher Syndrome. Pediatric Neurology 2013 48 3 167 178
32. Hirano M., Garone C., Quinzii C. M., CoQ10 deficiencies and MNGIE: two treatable mitochondrial disorders. Biochimica et Biophysica Acta-General Subjects 2012 1820 5 625 631 2-s2.0-84859436493 10.1016/j.bbagen.2012.01.006
33. El-Hattab A. W., Scaglia F., Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics 2013 10 2 186 198
34. DiMauro S., Schon E. A., Carelli V., The clinical maze of mitochondrial neurology. Nature Reviews Neurology 2013 9 429 444
35. Barzilai A., Rotman G., Shiloh Y., ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair 2002 1 1 3 25 2-s2.0-0036012789 10.1016/S1568-7864(01)00007-6 (Pubitemid 34475690)
36. Ambrose M., Goldstine J. V., Gatti R. A., Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Human Molecular Genetics 2007 16 18 2154 2164 2-s2.0-34548430918 10.1093/hmg/ddm166 (Pubitemid 47354898)
37. Degan P., d'Ischia M., Pallardó F. V., Zatterale A., Brusco A., Calzone R., Cavalieri S., Kavakli K., Lloret A., Manini P., Pisanti M. A., Vuttariello E., Pagano G., Glutathione levels in blood from ataxia telangiectasia patients suggest in vivo adaptive mechanisms to oxidative stress. Clinical Biochemistry 2007 40 9-10 666 670 2-s2.0-34249693700 10.1016/j.clinbiochem.2007.03.013 (Pubitemid 46829079)
38. Valentin-Vega Y. A., MacLean K. H., Tait-Mulder J., Milasta S., Steeves M., Dorsey F. C., Cleveland J. L., Green D. R., Kastan M. B., Mitochondrial dysfunction in ataxia-telangiectasia. Blood 2012 119 6 1490 1500 2-s2.0-84856893251 10.1182/blood-2011-08-373639
39. Shiloh Y., Tabor E., Becker Y., Abnormal response of ataxia- telangiectasia cells to agents that break the deoxyribose moiety of DNA via a targeted free radical mechanism. Carcinogenesis 1983 4 10 1317 1322 2-s2.0-0021041684 (Pubitemid 14229463)
40. Poot M., Hoehn H., Nicotera T. M., Rudiger H. W., Cell kinetic evidence suggests elevated oxidative stress in cultured cells of Bloom's syndrome. Free Radical Research Communications 1989 7 3-6 179 187 2-s2.0-0024449142 (Pubitemid 19281965)
41. Nicotera T. M., Molecular and biochemical aspects of Bloom's syndrome. Cancer Genetics and Cytogenetics 1991 53 1 1 13 2-s2.0-0025891758 10.1016/0165-4608(91)90109-8
42. Zatterale A., Kelly F. J., Degan P., d'Ischia M., Pallardó F. V., Calzone R., Dunster C., Lloret A., Manini P., Coulu O., Kavakli K., Pagano G., Oxidative stress biomarkers in four Bloom syndrome (BS) patients and in their parents suggest in vivo redox abnormalities in BS phenotype. Clinical Biochemistry 2007 40 15 1100 1110 2-s2.0-34548480978
43. Javeri A., Guy Lyons J., Huang X. X., Halliday G. M., Downregulation of Cockayne syndrome B protein reduces human 8-oxoguanine DNA glycosylase-1 expression and repair of UV radiation-induced 8-oxo-7,8-dihydro-2′- deoxyguanine. Cancer Science 2011 102 9 1651 1658 2-s2.0-80051810815 10.1111/j.1349-7006.2011.02005.x
44. Pascucci B., Lemma T., Iorio E., Giovannini S., Vaz B., Iavarone I., Calcagnile A., Narciso L., Degan P., Podo F., Roginskya V., Janjic B. M., van Houten B., Stefanini M., Dogliotti E., D'Errico M., An altered redox balance mediates the hypersensitivity of Cockayne syndrome primary fibroblasts to oxidative stress. Aging Cell 2012 11 3 520 529 2-s2.0-84859312983 10.1111/j.1474-9726.2012.00815.x
45. Scheibye-Knudsen M., Ramamoorthy M., Sykora P., Cockayne syndrome group B protein prevents the accumulation of damaged mitochondria by promoting mitochondrial autophagy. The Journal of Experimental Medicine 2012 209 4 855 869
46. Kamenisch Y., Berneburg M., Mitochondrial CSA and CSB: protein interactions and protection from ageing associated DNA mutations. Mechanisms of Ageing and Development 2013 134 5-6 270 274
47. Pallardó F. V., Degan P., d'Ischia M., Higher age-related prooxidant state in young Down syndrome patients indicates accelerated aging. Biogerontology 2006 7 4 211 220
48. Tiano L., Padella L., Carnevali P., Gabrielli O., Bruge F., Principi F., Littarru G. P., Coenzyme Q(10) and oxidative imbalance in Down syndrome: biochemical and clinical aspects. BioFactors 2008 32 1-4 161 167 2-s2.0-58149385696
49. Tiano L., Busciglio J., Mitochondrial dysfunction and Down's syndrome: is there a role for coenzyme Q(10)? BioFactors 2011 37 5 386 392 2-s2.0-80054875852 10.1002/biof.184
50. Valenti D., Manente G. A., Moro L., Marra E., Vacca R. A., Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway. Biochemical Journal 2011 435 3 679 688 2-s2.0-79954497176 10.1042/BJ20101908
51. Valenti D., de Rasmo D., Signorile A., Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down's syndrome. Biochimica et Biophysica Acta 2013 1832 4 542 552
52. Bambrick L. L., Fiskum G., Mitochondrial dysfunction in mouse trisomy 16 brain. Brain Research 2008 1188 1 9 16 2-s2.0-37349091097 10.1016/j.brainres. 2007.10.045 (Pubitemid 350296061)
53. Brooksbank B. W., Balazs R., Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain. Brain Research 1984 318 1 37 44 2-s2.0-0021485455 (Pubitemid 14046366)
54. Joenje H., Arwert F., Eriksson A. W., Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature 1981 290 5802 142 143 2-s2.0-0019444973 (Pubitemid 11149688)
55. Pagano G., Aiello Talamanca A., Castello G., From clinical description to in vitro and animal studies, and backwards to patients: oxidative stress and mitochondrial dysfunction in Fanconi anemia. Free Radical Biology and Medicine 2013 58 118 125
56. Du W., Rani R., Sipple J., The FA pathway counteracts oxidative stress through selective protection of antioxidant defense gene promoters. Blood 2012 119 18 4142 4151
57. Mukhopadhyay S. S., Leung K. S., Hicks M. J., Hastings P. J., Youssoufian H., Plon S. E., Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. The Journal of Cell Biology 2006 175 2 225 235 2-s2.0-33750378214 10.1083/jcb.200607061 (Pubitemid 44631417)
58. Kumari U., Jun W. Y., Bay B. H., Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi anemia cells. Oncogene 2013 33 2 165 172 10.1038/onc.2012.583
59. Ravera S., Vaccaro D., Cuccarolo P., Mitochondrial respiratory chain Complex I defects in Fanconi anemia complementation group A. Biochimie 2013 95 10 1828 1837
60. Pagano G., Aiello Talamanca A., Castello G., Bone marrow cell transcripts from Fanconi anaemia patients reveal in vivo alterations in mitochondrial, redox and DNA repair pathways. European Journal of Haematology 2013 91 2 141 151
61. Viteri G., Chung Y. W., Stadtman E. R., Effect of progerin on the accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford progeria patients. Mechanisms of Ageing and Development 2010 131 1 2 8 2-s2.0-74149087114 10.1016/j.mad.2009.11.006
62. Richards S. A., Muter J., Ritchie P., Lattanzi G., Hutchison C. J., The accumulation of un-repairable DNA damage in laminopathy progeria fibroblasts is caused by ROS generation and is prevented by treatment with N-acetyl cysteine. Human Molecular Genetics 2011 20 20 3997 4004 2-s2.0-80053150156 10.1093/hmg/ddr327
63. Turinetto V., Porcedda P., Minieri V., Orlando L., Lantelme E., Accomasso L., Amoroso A., de Marchi M., Zannini L., Delia D., Giachino C., A novel defect in mitochondrial p53 accumulation following DNA damage confers apoptosis resistance in Ataxia Telangiectasia and Nijmegen Breakage Syndrome T-cells. DNA Repair 2010 9 11 1200 1208 2-s2.0-78049375911 10.1016/j.dnarep.2010.09.003
64. Krenzlin H., Demuth I., Salewsky B., Wessendorf P., Weidele K., Bürkle A., Digweed M., DNA damage in nijmegen breakage syndrome cells leads to PARP hyperactivation and increased oxidative stress. PLoS Genetics 2012 8 3 2-s2.0-84859248021 10.1371/journal.pgen.1002557 e1002557
65. Woo L. L., Futami K., Shimamoto A., Furuichi Y., Frank K. M., The Rothmund-Thomson gene product RECQL4 localizes to the nucleolus in response to oxidative stress. Experimental Cell Research 2006 312 17 3443 3457 2-s2.0-33748606377 10.1016/j.yexcr.2006.07.023 (Pubitemid 44380243)
66. Davis T., Tivey H. S., Brook A. J., Activation of p38 MAP kinase and stress signalling in fibroblasts from the progeroid Rothmund-Thomson syndrome. Age 2013 35 5 1767 1783
67. Croteau D. L., Rossi M. L., Canugovi C., Tian J., Sykora P., Ramamoorthy M., Wang Z., Singh D. K., Akbari M., Kasiviswanathan R., Copeland W. C., Bohr V. A., RECQL4 localizes to mitochondria and preserves mitochondrial DNA integrity. Aging Cell 2012 11 3 456 466 2-s2.0-84857680437 10.1111/j.1474-9726.2012.00803. x
68. Pallardó F. V., Lloret A., Lebel M., D'Ischia M., Cogger V. C., Le Couteur D. G., Gadaleta M. N., Castello G., Pagano G., Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome. Biogerontology 2010 11 4 401 419 2-s2.0-77954938829 10.1007/s10522-010-9269-4
69. Bohr V. A., Cooper M., Orren D., Machwe A., Piotrowski J., Sommers J., Karmakar P., Brosh R., Werner syndrome protein: biochemical properties and functional interactions. Experimental Gerontology 2000 35 6-7 695 702 2-s2.0-0033792458 10.1016/S0531-5565(00)00145-5
70. von Kobbe C., May A., Grandori C., Bohr V. A., Werner syndrome cells escape hydrogen peroxide-induced cell proliferation arrest. The FASEB Journal 2004 18 15 1970 1972 2-s2.0-10044271919 10.1096/fj.04-1895fje (Pubitemid 39602301)
71. Pagano G., Zatterale A., Degan P., d'Ischia M., Kelly F. J., Pallardó F. V., Kodama S., Multiple involvement of oxidative stress in Werner syndrome phenotype. Biogerontology 2005 6 4 233 243 2-s2.0-31044435620 10.1007/s10522-005-2624-1 (Pubitemid 43118462)
72. Lloret A., Calzone R., Dunster C., Manini P., d'Ischia M., Degan P., Kelly F. J., Pallardó F. V., Zatterale A., Pagano G., Different patterns of in vivo pro-oxidant states in a set of cancer- or aging-related genetic diseases. Free Radical Biology and Medicine 2008 44 4 495 503 2-s2.0-38649125578 10.1016/j.freeradbiomed.2007.10.046
73. Hayashi M., Roles of oxidative stress in xeroderma pigmentosum. Advances in Experimental Medicine and Biology 2008 637 120 127 2-s2.0-60549092906 10.1007/978-0-387-09599-8-13
74. Ting A. P. L., Low G. K. M., Gopalakrishnan K., Hande M. P., Telomere attrition and genomic instability in xeroderma pigmentosum type-b deficient fibroblasts under oxidative stress. Journal of Cellular and Molecular Medicine 2010 14 1-2 403 416 2-s2.0-77951950271 10.1111/j.1582-4934.2009.00945.x
75. Rezvani H. R., Rossignol R., Ali N., Benard G., Tang X., Yang H. S., Jouary T., de Verneuil H., Taïeb A., Kim A. L., Mazurier F., XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species. Biochimica et Biophysica Acta-Bioenergetics 2011 1807 6 609 619 2-s2.0-79955611732 10.1016/j.bbabio.2010. 12.006
76. Tanaka J., Nagai T., Okada S., Serum concentration of coenzyme Q in xeroderma pigmentosum. Clinical Neurology 1998 38 1 57 59 2-s2.0-0031957207 (Pubitemid 28218009)
77. Xia X., Werner D., Popanda O., Thielmann H. W., Expression of mitochondrial genes and DNA-repair-related nuclear genes is altered in xeroderma pigmentosum fibroblasts. The Journal of Cancer Research and Clinical Oncology 1994 120 8 454 464 2-s2.0-0028229318 10.1007/BF01191798 (Pubitemid 24205121)
78. Deon M., Sitta A., Barschak A. G., Coelho D. M., Pigatto M., Schmitt G. O., Jardim L. B., Giugliani R., Wajner M., Vargas C. R., Induction of lipid peroxidation and decrease of antioxidant defenses in symptomatic and asymptomatic patients with X-linked adrenoleukodystrophy. International Journal of Developmental Neuroscience 2007 25 7 441 444 2-s2.0-36049050412 10.1016/j.ijdevneu.2007.08.008 (Pubitemid 350086846)
79. Petrillo S., Piemonte F., Pastore A., Glutathione imbalance in patients with X-linked adrenoleukodystrophy. Molecular Genetics and Metabolism 2013 109 4 366 370
80. Schlüter A., Espinosa L., Fourcade S., Galino J., Lśpez E., Ilieva E., Morató L., Asheuer M., Cook T., McLaren A., Reid J., Kelly F., Bates S., Aubourg P., Galea E., Pujol A., Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy. Human Molecular Genetics 2012 21 5 1062 1077 2-s2.0-84856955371 10.1093/hmg/ddr536
81. López-Erauskin J., Galino J., Ruiz M., Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy. Human Molecular Genetics 2013 22 16 3296 3305
82. Fourcade S., López-Erauskin J., Ruiz M., Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy. Biochimie 2014 98 143 149 10.1016/j.biochi.2013.09.012
83. Terrill J. R., Radley-Crabb H. G., Iwasaki T., Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies. FEBS Journal 2013 280 17 4149 4164
84. Renjini R., Gayathri N., Nalini A., Srinivas Bharath M. M., Oxidative damage in muscular dystrophy correlates with the severity of the pathology: role of glutathione metabolism. Neurochemical Research 2012 37 4 885 898 2-s2.0-84855219136 10.1007/s11064-011-0683-z
85. Percival J. M., Siegel M. P., Knowels G., Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition. Human Molecular Genetics 2013 22 1 153 167
86. Cooper J. M., Korlipara L. V. P., Hart P. E., Bradley J. L., Schapira A. H. V., Coenzyme Q(10) and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin e and coenzyme Q(10) therapy. The European Journal of Neurology 2008 15 12 1371 1379 2-s2.0-56049088295 10.1111/j.1468-1331.2008. 02318.x
87. Sparaco M., Gaeta L. M., Santorelli F. M., Passarelli C., Tozzi G., Bertini E., Simonati A., Scaravilli F., Taroni F., Duyckaerts C., Feleppa M., Piemonte F., Friedreich's ataxia: oxidative stress and cytoskeletal abnormalities. The Journal of the Neurological Sciences 2009 287 1-2 111 118 2-s2.0-70350622327 10.1016/j.jns.2009.08.052
88. Santos R., Lefevre S., Sliwa D., Seguin A., Camadro J., Lesuisse E., Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities. Antioxidants and Redox Signaling 2010 13 5 651 690 2-s2.0-77954930779 10.1089/ars.2009.3015
89. Hyson H. C., Kieburtz K., Shoulson I., McDermott M., Ravina B., de Blieck E. A., Cudkowicz M. E., Ferrante R. J., Safety and tolerability of high-dosage coenzyme Q(10) in Huntington's disease and healthy subjects. Movement Disorders 2010 25 12 1924 1928 2-s2.0-77956802394 10.1002/mds.22408
90. Valencia A., Sapp E., Kimm J. S., Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease. Human Molecular Genetics 2013 22 6 1112 1131
91. Yang L., Calingasan N. Y., Wille E. J., Cormier K., Smith K., Ferrante R. J., Flint Beal M., Combination therapy with Coenzyme Q(10) and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases. Journal of Neurochemistry 2009 109 5 1427 1439 2-s2.0-65549091910 10.1111/j.1471-4159.2009.06074.x
92. Ribeiro M., Silva A. C., Rodrigues J., Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells-protective effect of cystamine and creatine. Toxicological Sciences 2013 136 2 487 499 10.1093/toxsci/kft199
93. Tyagi N., Ovechkin A. V., Lominadze D., Moshal K. S., Tyagi S. C., Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia. Journal of Cellular Biochemistry 2006 98 5 1150 1162 2-s2.0-33746543557 10.1002/jcb.20837 (Pubitemid 44131429)
94. Moshal K. S., Tipparaju S. M., Vacek T. P., Kumar M., Singh M., Frank I. E., Patibandla P. K., Tyagi N., Rai J., Metreveli N., Rodriguez W. E., Tseng M. T., Tyagi S. C., Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. The American Journal of Physiology-Heart and Circulatory Physiology 2008 295 2 H890 H897 2-s2.0-52449119107 10.1152/ajpheart.00099.2008
95. Vanzin C. S., Biancini G. B., Sitta A., Wayhs C. A. Y., Pereira I. N., Rockenbach F., Garcia S. C., Wyse A. T. D. S., Schwartz I. V. D., Wajner M., Vargas C. R., Experimental evidence of oxidative stress in plasma of homocystinuric patients: a possible role for homocysteine. Molecular Genetics and Metabolism 2011 104 1-2 112 117 2-s2.0-80052546167 10.1016/j.ymgme.2011.06. 013
96. Nur E., Brandjes D. P., Schnog J. B., Otten H., Fijnvandraat K., Schalkwijk C. G., Biemond B. J., Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients. British Journal of Haematology 2010 151 1 62 69 2-s2.0-77956824847 10.1111/j.1365-2141.2010.08320.x
97. Amer J., Ghoti H., Rachmilewitz E., Koren A., Levin C., Fibach E., Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. British Journal of Haematology 2006 132 1 108 113 2-s2.0-33644792819 10.1111/j.1365-2141.2005.05834.x (Pubitemid 43381577)
98. Grasso J. A., Sullivan A. L., Sullivan L. W., Ultrastructural studies of the bone marrow in sickle cell anaemia. I. The structure of sickled erythrocytes and reticulocytes and their phagocytic destruction. British Journal of Haematology 1975 31 2 135 148 2-s2.0-0016838875
99. Hershko C., Pathogenesis and management of iron toxicity in thalassemia. Annals of the New York Academy of Sciences 2010 1202 1 9 2-s2.0-77955915545 10.1111/j.1749-6632.2010.05544.x
100. Ferro E., Visalli G., Civa R., Oxidative damage and genotoxicity biomarkers in transfused and untransfused thalassemic subjects. Free Radical Biology and Medicine 2012 53 10 1829 1837
101. Tsagris V., Liapi-Adamidou G., Serum carnitine levels in patients with homozygous beta thalassemia: a possible new role for carnitine? European Journal of Pediatrics 2005 164 3 131 134 2-s2.0-17644398472 10.1007/s00431-004-1590-y (Pubitemid 40558174)
102. Rebrin I., Sohal R. S., Pro-oxidant shift in glutathione redox state during aging. Advanced Drug Delivery Reviews 2008 60 13-14 1545 1552 2-s2.0-51249104026 10.1016/j.addr.2008.06.001
103. Møller P., Løhr M., Folkmann J. K., Mikkelsen L., Loft S., Aging and oxidatively damaged nuclear DNA in animal organs. Free Radical Biology and Medicine 2010 48 10 1275 1285 2-s2.0-77951938325 10.1016/j.freeradbiomed. 2010.02.003
104. Cau S. B., Carneiro F. S., Tostes R. C., Differential modulation of nitric oxide synthases in aging: therapeutic opportunities. Frontiers in Physiology 2012 3 article 218
105. Musicco C., Capelli V., Pesce V., Timperio A. M., Calvani M., Mosconi L., Zolla L., Cantatore P., Gadaleta M. N., Accumulation of overoxidized Peroxiredoxin III in aged rat liver mitochondria. Biochimica et Biophysica Acta-Bioenergetics 2009 1787 7 890 896 2-s2.0-67649268322 10.1016/j.bbabio.2009. 03.002
106. Wang C. H., Wu S. B., Wu Y. T., Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Experimental Biology and Medicine 2013 238 5 450 460
107. Gomez-Cabrera M. C., Sanchis-Gomar F., Garcia-Valles R., Mitochondria as sources and targets of damage in cellular aging. Clinical Chemistry and Laboratory Medicine 2012 50 8 1287 1295
108. Takimoto E., Kass D. A., Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 2007 49 2 241 248 2-s2.0-33846418746 10.1161/01.HYP.0000254415.31362.a7 (Pubitemid 46142995)
109. Victor V. M., Rocha M., Solá E., Bañuls C., Garcia-Malpartida K., Hernández-Mijares A., Oxidative stress, endothelial dysfunction and atherosclerosis. Current Pharmaceutical Design 2009 15 26 2988 3002 2-s2.0-70449458051 10.2174/138161209789058093
110. Di Lisa F., Kaludercic N., Carpi A., Menabò R., Giorgio M., Mitochondria and vascular pathology. Pharmacological Reports 2009 61 1 123 130 2-s2.0-66949176522
111. Perrotta I., Perrotta E., Sesti S., MnSOD expression in human atherosclerotic plaques: an immunohistochemical and ultrastructural study. Cardiovascular Pathology 2013 22 6 428 437
112. Sobenin I. A., Sazonova M. A., Postnov A. Y., Changes of mitochondria in atherosclerosis: possible determinant in the pathogenesis of the disease. Atherosclerosis 2013 227 2 283 288
113. Guzik B., Sagan A., Ludew D., Mechanisms of oxidative stress in human aortic aneurysms-association with clinical risk factors for atherosclerosis and disease severity. International Journal of Cardiology 2013 168 3 2389 2396
114. Hansel B., Giral P., Nobecourt E., Chantepie S., Bruckert E., Chapman M. J., Kontush A., Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. The Journal of Clinical Endocrinology and Metabolism 2004 89 10 4963 4971 2-s2.0-6344267152 10.1210/jc.2004-0305 (Pubitemid 39391435)
115. Palmieri V. O., Grattagliano I., Portincasa P., Palasciano G., Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. The Journal of Nutrition 2006 136 12 3022 3026 2-s2.0-33845313622 (Pubitemid 44878567)
116. Koene S., Rodenburg R. J., van der Knaap M. S., Natural disease course and genotype-phenotype correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 cases. Journal of Inherited Metabolic Diseases 2012 35 5 737 747
117. Huang C., Su S., Hsieh M., Cheng W., Chang C., Wu H., Kuo C., Lin T., Liu C., Depleted leukocyte mitochondrial DNA copy number in metabolic syndrome. Journal of Atherosclerosis and Thrombosis 2011 18 10 867 873 2-s2.0-80155171893 10.5551/jat.8698
118. Mitchell T., Darley-Usmar V., Metabolic syndrome and mitochondrial dysfunction: insights from preclinical studies with a mitochondrially targeted antioxidant. Free Radical Biology and Medicine 2012 52 5 838 840 2-s2.0-84856730277 10.1016/j.freeradbiomed.2011.12.014
119. Auinger A., Rubin D., Sabandal M., A common haplotype of carnitine palmitoyltransferase 1b is associated with the metabolic syndrome. British Journal of Nutrition 2013 109 5 810 815
120. Altindag O., Erel O., Aksoy N., Selek S., Celik H., Karaoglanoglu M., Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatology International 2007 27 4 339 344 2-s2.0-33846298900 10.1007/s00296-006-0247-8 (Pubitemid 46122276)
121. Fernandez-Moreno M., Soto-Hermida A., Pertega S., Oreiro N., Fernandez-Lopez C., Rego-Perez I., Blanco F. J., Mitochondrial DNA (mtDNA) haplogroups and serum levels of anti-oxidant enzymes in patients with osteoarthritis. BMC Musculoskeletal Disorders 2011 12, article 264 2-s2.0-81455161607 10.1186/1471-2474-12-264
122. Li Z., Shen J., Chen Y., Mitochondrial genome sequencing of chondrocytes in osteoarthritis by human mitochondria RT2 Profiler PCR array. Molecular Medicine Reports 2012 6 1 39 44
123. Fernández-Moreno M., Soto-Hermida A., Oreiro N., Mitochondrial haplogroups define two phenotypes of osteoarthritis. Frontiers in Physiology 2012 3 article 129
124. Gavrilidis C., Miwa S., von Zglinicki T., Mitochondrial dysfunction in osteoarthritis is associated with down-regulation of superoxide dismutase 2. Arthritis and Rheumatism 2013 65 5 378 387
125. Tabak O., Gelisgen R., Erman H., Erdenen F., Muderrisoglu C., Aral H., Uzun H., Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. Clinical and Investigative Medicine 2011 34 3 E163 E171 2-s2.0-80051777094
126. Remor A. P., de Matos F. J., Ghisoni K., da Silva T. L., Eidt G., Búrigo M., de Bem A. F., Silveira P. C. L., de León A., Sanchez M. C., Hohl A., Glaser V., Gonçalves C., Quincozes-Santos A., Borba Rosa R., Latini A., Differential effects of insulin on peripheral diabetes-related changes in mitochondrial bioenergetics: involvement of advanced glycosylated end products. Biochimica et Biophysica Acta-Molecular Basis of Disease 2011 1812 11 1460 1471 2-s2.0-80053460459 10.1016/j.bbadis.2011.06.017
127. Bansal S., Siddarth M., Chawla D., Banerjee B. D., Madhu S. V., Tripathi A. K., Advanced glycation end products enhance reactive oxygen and nitrogen species generation in neutrophils in vitro. Molecular and Cellular Biochemistry 2012 361 1-2 289 296 2-s2.0-84860245308
128. Noriega-Cisneros R., Cortés-Rojo C., Manzo-Avalos S., Mitochondrial response to oxidative and nitrosative stress in early stages of diabetes. Mitochondrion 2013 13 6 835 840
129. Amer M. A., Ghattas M. H., Abo-Elmatty D. M., Influence of glutathione S-transferase polymorphisms on type-2 diabetes mellitus risk. Genetics and Molecular Research 2011 10 4 3722 3730
130. Khan S., Raghuram G. V., Bhargava A., Pathak N., Chandra D. H., Jain S. K., Mishra P. K., Role and clinical significance of lymphocyte mitochondrial dysfunction in type 2 diabetes mellitus. Translational Research 2011 158 6 344 359 2-s2.0-80755125985 10.1016/j.trsl.2011.08.007
131. Avila C., Huang R. J., Stevens M. V., Aponte A. M., Tripodi D., Kim K. Y., Sack M. N., Platelet mitochondrial dysfunction is evident in type 2 diabetes in association with modifications of mitochondrial anti-oxidant stress proteins. Experimental and Clinical Endocrinology and Diabetes 2012 120 4 248 251 2-s2.0-84860251058 10.1055/s-0031-1285833
132. Calabrese V., Cornelius C., Leso V., Trovato-Salinaro A., Ventimiglia B., Cavallaro M., Scuto M., Rizza S., Zanoli L., Neri S., Castellino P., Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochimica et Biophysica Acta-Molecular Basis of Disease 2012 1822 5 729 736 2-s2.0-84858152480 10.1016/j.bbadis.2011.12.003
133. Gray S. P., Di Marco E., Okabe J., NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis. Circulation 2013 127 18 1888 1902
134. Area-Gomez E., Del Carmen Lara Castillo M., Tambini M. D., Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. The EMBO Journal 2012 31 21 4106 4123
135. Atamna H., Frey W. H. II, Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease. Mitochondrion 2007 7 5 297 310 2-s2.0-34548133215 10.1016/j.mito.2007.06.001 (Pubitemid 47300175)
136. Dumont M., Kipiani K., Yu F., Wille E., Katz M., Calingasan N. Y., Gouras G. K., Lin M. T., Beal M. F., Coenzyme Q(10) decreases amyloid pathology and improves behavior in a transgenic mouse model of alzheimer's disease. The Journal of Alzheimer's Disease 2011 27 1 211 223 2-s2.0-80155191237 10.3233/JAD-2011-110209
137. Murakami K., Murata N., Noda Y., Stimulation of the amyloidogenic pathway by cytoplasmic superoxide radicals in an Alzheimer's disease mouse model. Bioscience, Biotechnology, and Biochemistry 2012 76 6 1098 1103
138. Hardas S. S., Sultana R., Clark A. M., Oxidative modification of lipoic acid by HNE in Alzheimer disease brain. Redox Biology 2013 1 1 80 85
139. Aliev G., Palacios H. H., Gasimov E., Obrenovich M. E., Morales L., Leszek J., Bragin V., Herrera A. S., Gokhman D., Oxidative stress induced mitochondrial failure and vascular hypoperfusion as a key initiator for the development of alzheimer disease. Pharmaceuticals 2010 3 1 158 187 2-s2.0-77951964504 10.3390/ph3010158
140. Zarrouk A., Vejux A., Nury T., Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E). Oxidative Medicine and Cellular Longevity 2012 2012 15 623257 10.1155/2012/623257
141. Kou J., Kovacs G. G., Höftberger R., Peroxisomal alterations in Alzheimer's disease. Acta Neuropathologica 2011 122 3 271 283
142. Cozzolino M., Carrì M. T., Mitochondrial dysfunction in ALS. Progress in Neurobiology 2012 97 2 54 66
143. Cova E., Bongioanni P., Cereda C., Metelli M. R., Salvaneschi L., Bernuzzi S., Guareschi S., Rossi B., Ceroni M., Time course of oxidant markers and antioxidant defenses in subgroups of amyotrophic lateral sclerosis patients. Neurochemistry International 2010 56 5 687 693 2-s2.0-77949569546 10.1016/j.neuint.2010.02.004
144. Karch C. M., Prudencio M., Winkler D. D., Hart P. J., Borchelt D. R., Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proceedings of the National Academy of Sciences of the United States of America 2009 106 19 7774 7779 2-s2.0-66049156169 10.1073/pnas. 0902505106
145. Rodríguez G. E., González D. M., Monachelli G. M., Morphological abnormalities in mitochondria of the skin of patients with sporadic amyotrophic lateral sclerosis. Arquivos de Neuro-Psiquiatria 2012 70 1 40 44
146. Ghiasi P., Hosseinkhani S., Noori A., Nafissi S., Khajeh K., Mitochondrial complex I deficiency and ATP/ADP ratio in lymphocytes of amyotrophic lateral sclerosis patients. Neurological Research 2012 34 3 297 303 2-s2.0-84859338362 10.1179/1743132812Y.0000000012
147. Chuang Y., Mitochondrial dysfunction and oxidative stress in seizure-induced neuronal cell death. Acta Neurologica Taiwanica 2010 19 1 3 15 2-s2.0-77950642047
148. Malinska D., Kulawiak B., Kudin A. P., Kovacs R., Huchzermeyer C., Kann O., Szewczyk A., Kunz W. S., Complex III-dependent superoxide production of brain mitochondria contributes to seizure-related ROS formation. Biochimica et Biophysica Acta-Bioenergetics 2010 1797 6-7 1163 1170 2-s2.0-77953810225 10.1016/j.bbabio.2010.03.001
149. Mayr J. A., Zimmermann F. A., Fauth C., Bergheim C., Meierhofer D., Radmayr D., Zschocke J., Koch J., Sperl W., Lipoic acid synthetase deficiency causes neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation. American Journal of Human Genetics 2011 89 6 792 797 2-s2.0-83455253737 10.1016/j.ajhg.2011.11.011
150. García-Giménez J. L., Seco-Cervera M., Aguado C., Lafora disease fibroblasts exemplify the molecular interdependence between thioredoxin 1 and the proteasome in mammalian cells. Free Radical Biology and Medicine C 2013 65 347 359
151. Booth N. E., Myhill S., McLaren-Howard J., Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). International Journal of Clinical and Experimental Medicine 2012 5 3 208 220
152. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E., Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuroendocrinology Letters 2009 30 6 715 722 2-s2.0-77649266722
153. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E., Coenzyme Q(10) deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuroendocrinology Letters 2009 30 4 470 476 2-s2.0-76049126501
154. Maes M., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E., Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS). Medical Science Monitor 2011 17 4 SC11 SC15 2-s2.0-79953744583
155. Jammes Y., Steinberg J. G., Delliaux S., Chronic fatigue syndrome: acute infection and history of physical activity affect resting levels and response to exercise of plasma oxidant/antioxidant status and heat shock proteins. Journal of Internal Medicine 2012 272 1 74 84 2-s2.0-84855286490 10.1111/j.1365-2796. 2011.02488.x
156. Smits B., van den Heuvel L., Knoop H., Küsters B., Janssen A., Borm G., Bleijenberg G., Rodenburg R., van Engelen B., Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome. Mitochondrion 2011 11 5 735 738 2-s2.0-79961207300 10.1016/j.mito.2011.05.005
157. Miller E., Walczak A., Saluk J., Ponczek M. B., Majsterek I., Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis. Clinical Biochemistry 2012 45 1-2 26 30 2-s2.0-84855301917 10.1016/j.clinbiochem.2011.09.021
158. Fischer M. T., Sharma R., Lim J. L., Haider L., Frischer J. M., Drexhage J., Mahad D., Bradl M., van Horssen J., Lassmann H., NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 2012 135 part 3 886 899 2-s2.0-84857538385 10.1093/brain/aws012
159. Campbell G. R., Mahad D. J., Clonal expansion of mitochondrial DNA deletions and the progression of multiple sclerosis. CNS and Neurological Disorders-Drug Targets 2012 11 5 589 597
160. Miller E., Walczak A., Majsterek I., Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course. Journal of Neuroimmunology 2013 257 1-2 97 101
161. Seet R. C. S., Lee C. J., Lim E. C. H., Tan J. J. H., Quek A. M. L., Chong W., Looi W., Huang S., Wang H., Chan Y., Halliwell B., Oxidative damage in Parkinson disease: measurement using accurate biomarkers. Free Radical Biology and Medicine 2010 48 4 560 566 2-s2.0-74149087316 10.1016/j.freeradbiomed.2009. 11.026
162. Mischley L. K., Allen J., Bradley R., Coenzyme Q(10) deficiency in patients with Parkinson's disease. The Journal of the Neurological Sciences 2012 318 1-2 72 75 2-s2.0-84860180203 10.1016/j.jns.2012.03.023
163. Naoi M., Maruyama W., Shamoto-Nagai M., Yi H., Akao Y., Tanaka M., Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Molecular Neurobiology 2005 31 1-3 81 93 2-s2.0-24644443158 (Pubitemid 41271195)
164. Danielson S. R., Held J. M., Oo M., Riley R., Gibson B. W., Andersen J. K., Quantitative mapping of reversible mitochondrial complex I cysteine oxidation in a Parkinson disease mouse model. The Journal of Biological Chemistry 2011 286 9 7601 7608 2-s2.0-79953223335 10.1074/jbc.M110.190108
165. Cacciatore I., Baldassarre L., Fornasari E., Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems. Oxidative Medicine and Cellular Longevity 2012 2012 12 240146 10.1155/2012/240146
166. Rose S., Melnyk S., Trusty T. A., Intracellular and extracellular redox status and free radical generation in primary immune cells from children with autism. Autism Research and Treatment 2012 2012 10 986519 10.1155/2012/986519
167. Pecorelli A., Leoncini S., de Felice C., Signorini C., Cerrone C., Valacchi G., Ciccoli L., Hayek J., Non-protein-bound iron and 4-hydroxynonenal protein adducts in classic autism. Brain and Development 2013 35 2 146 154 2-s2.0-84859927915 10.1016/j.braindev.2012.03.011
168. Frustaci A., Neri M., Cesario A., Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radical Biology and Medicine 2012 52 10 2128 2141
169. Rose S., Melnyk S., Pavliv O., Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Translational Psychiatry 2012 2 article e134
170. Anitha A., Nakamura K., Thanseem I., Downregulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathology 2013 23 3 294 302
171. Napoli E., Wong S., Giulivi C., Evidence of reactive oxygen species-mediated damage to mitochondrial DNA in children with typical autism. Molecular Autism 2013 4 1 2
172. Ross-Inta C., Omanska-Klusek A., Wong S., Barrow C., Garcia-Arocena D., Iwahashi C., Berry-Kravis E., Hagerman R. J., Hagerman P. J., Giulivi C., Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome. Biochemical Journal 2010 429 3 545 552 2-s2.0-77955071201 10.1042/BJ20091960
173. +-ATPase activity and lipid peroxidation in bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012 37 1 56 61 2-s2.0-84857789619 10.1016/j.pnpbp.2011.12.006
174. Raffa M., Barhoumi S., Atig F., Reduced antioxidant defense systems in schizophrenia and bipolar I disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012 39 2 371 375
175. Andreazza A. C., Wang J. F., Salmasi F., Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. Journal of Neurochemistry 2013 127 4 552 561
176. Rawdin B. S., Mellon S. H., Dhabhar F. S., Dysregulated relationship of inflammation and oxidative stress in major depression. Brain, Behavior, and Immunity 2013 31 1 143 152
177. Szuster-Ciesielska A., Słotwińska M., Stachura A., Marmurowska-Michałowska H., Dubas-Ślemp H., Bojarska-Junak A., Kandefer-Szerszeń M., Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008 32 3 686 694 2-s2.0-39749149696 10.1016/j.pnpbp.2007.11.012 (Pubitemid 351312366)
178. Gibson S. A., Korade Ž., Shelton R. C., Oxidative stress and glutathione response in tissue cultures from persons with major depression. Journal of Psychiatric Research 2012 46 10 1326 1632
179. Ben-Shachar D., Karry R., Neuroanatomical pattern of mithochondrial complex I pathology varies between schizoprenia, bipolar disorder and major depression. PLoS ONE 2008 3 11 2-s2.0-56649111125 10.1371/journal.pone.0003676 e3676
180. Chakraborty S., Singh O. P., Dasgupta A., Mandal N., Das H. N., Correlation between lipid peroxidation-induced TBARS level and disease severity in obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009 33 2 363 366 2-s2.0-60049086948 10.1016/j.pnpbp.2009. 01.001
181. Behl A., Swami G., Sircar S. S., Bhatia M. S., Banerjee B. D., Relationship of possible stress-related biochemical markers to oxidative/antioxidative status in obsessive-compulsive disorder. Neuropsychobiology 2010 61 4 210 214 2-s2.0-77950613465 10.1159/000306591
182. Orhan N., Kucukali C. I., Cakir U., Seker N., Aydin M., Genetic variants in nuclear-encoded mitochondrial proteins are associated with oxidative stress in obsessive compulsive disorders. Journal of Psychiatric Research 2012 46 2 212 218 2-s2.0-84856002068 10.1016/j.jpsychires.2011.09.012
183. Anderson G., Maes M., Berk M., Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2013 42 101 114
184. Pedrini M., Massuda R., Fries G. R., de Bittencourt Pasquali M. A., Schnorr C. E., F. Moreira J. C., Teixeira A. L., R. Lobato M. I., Walz J. C., Belmonte-de-Abreu P. S., Kauer-Sant'Anna M., Kapczinski F., Gama C. S., Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity. Journal of Psychiatric Research 2012 46 6 819 824 2-s2.0-84859795595 10.1016/j.jpsychires.2012.03.019
185. Kulak A., Steullet P., Cabungcal J. H., Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models. Antioxidants and Redox Signaling 2012 18 12 1428 1443
186. Zhang X. Y., Chen D. C., Xiu M. H., Tang W., Zhang F., Liu L., Chen Y., Liu J., Yao J. K., Kosten T. A., Kosten T. R., Plasma total antioxidant status and cognitive impairments in schizophrenia. Schizophrenia Research 2012 139 1-3 66 72 2-s2.0-84860554683 10.1016/j.schres.2012.04.009
187. Gubert C., Stertz L., Pfaffenseller B., Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. Journal of Psychiatric Research 2013 47 10 1396 1402
188. Costa A., Scholer-Dahirel A., Mechta-Grigoriou F., The role of reactive oxygen species and metabolism on cancer cells and their microenvironment. Seminars in Cancer Biology 2014 10.1016/j.semcancer.2013.12.007
189. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation. Cell 2011 144 5 646 674 2-s2.0-79952284127 10.1016/j.cell.2011.02.013
190. Masoudi-Nejad A., Asgari Y., Metabolic Cancer Biology: structural-based analysis of cancer as a metabolic disease, new sights and opportunities for disease treatment. Seminars in Cancer Biology 2014 10.1016/j.semcancer.2014.01. 007
191. Soini Y., Haapasaari K., Vaarala M. H., Turpeenniemi-Hujanen T., Kärjä V., Karihtala P., 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma. International Journal of Clinical and Experimental Pathology 2011 4 3 267 275 2-s2.0-80051609028
192. Badjatia N., Satyam A., Singh P., Seth A., Sharma A., Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. Urologic Oncology: Seminars and Original Investigations 2010 28 4 360 367 2-s2.0-77953852662 10.1016/j.urolonc.2008.12.010
193. Guney A. I., Ergec D. S., Tavukcu H. H., Detection of mitochondrial DNA mutations in nonmuscle invasive bladder cancer. Genetic Testing and Molecular Biomarkers 2012 16 7 672 678
194. Niu H. T., Yang C. M., Jiang G., Xu T., Cao Y. W., Zhao J., Wang X. S., Cancer stroma proteome expression profile of superficial bladder transitional cell carcinoma and biomarker discovery. The Journal of Cancer Research and Clinical Oncology 2011 137 8 1273 1282 2-s2.0-79961173463 10.1007/s00432-011- 0995-z
195. Kedzierska M., Olas B., Wachowicz B., Jeziorski A., Piekarski J., Relationship between thiol, tyrosine nitration and carbonyl formation as biomarkers of oxidative stress and changes of hemostatic function of plasma from breast cancer patients before surgery. Clinical Biochemistry 2012 45 3 231 236 2-s2.0-84856502096 10.1016/j.clinbiochem.2011.12.002
196. Pande D., Negi R., Karki K., Oxidative damage markers as possible discriminatory biomarkers in breast carcinoma. Translational Research 2012 160 6 411 418
197. Martinez-Outschoorn U. E., Balliet R., Lin Z., BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies. Cell Cycle 2012 11 23 4402 4413
198. Salem A. F., Howell A., Sartini M., Downregulation of stromal BRCA1 drives breast cancer tumor growth via upregulation of HIF-1 α autophagy and ketone body production. Cell Cycle 2012 11 22 4167 4173
199. Sotgia F., Whitaker-Menezes D., Martinez-Outschoorn U. E., Mitochondria, "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cell. Cell Cycle 2012 11 23 4390 4401
200. Coene E. D., Hollinshead M. S., Waeytens A. A. T., Schelfhout V. R. J., Eechaute W. P., Shaw M. K., van Oostveldt P. M. V., Vaux D. J., Phosphorylated BRCA1 is predominantly located in the nucleus and mitochondria. Molecular Biology of the Cell 2005 16 2 997 1010 2-s2.0-12844280448 10.1091/mbc.E04-10- 0895 (Pubitemid 40165588)
201. Cooney R. V., Dai Q., Gao Y., Chow W., Franke A. A., Shu X., Li H., Ji B., Cai Q., Chai W., Zheng W., Low plasma coenzyme Q(10) levels and breast cancer risk in Chinese women. Cancer Epidemiology Biomarkers and Prevention 2011 20 6 1124 1130 2-s2.0-79958057003 10.1158/1055-9965.EPI-10-1261
202. Looi M., Ahmad Zailani Hatta A. Z. H., Dali A. Z. H. M., Ali S. A. M., Ngah W. Z. W., Yusof Y. A. M., Oxidative damage and antioxidant status in patients with cervical intraepithelial neoplasia and carcinoma of the cervix. European Journal of Cancer Prevention 2008 17 6 555 560 2-s2.0-56149124658 10.1097/CEJ.0b013e328305a10b
203. Li L., Chen C., Cao Z., Liao Q., Du H., Zhan S., Zhou L., Zeng Y., Expression of peroxiredoxin III cervical lesions. ZZhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2009 23 6 443 445 2-s2.0-77956636859
204. Srivastava S., Natu S. M., Gupta A., Pal K. A., Singh U., Agarwal G. G., Singh U., Goel M. M., Srivastava A. N., Lipid peroxidation and antioxidants in different stages of cervical cancer: prognostic significance. Indian Journal of Cancer 2009 46 4 297 302 2-s2.0-70349432508 10.4103/0019-509X.55549
205. Sharma A., Rajappa M., Satyam A., Sharma M., Oxidant/anti-oxidant dynamics in patients with advanced cervical cancer: correlation with treatment response. Molecular and Cellular Biochemistry 2010 341 1-2 65 72 2-s2.0-77955013686 10.1007/s11010-010-0437-2
206. de Marco F., Bucaj E., Foppoli C., Fiorini A., Blarzino C., Filipi K., Giorgi A., Schininà M. E., Di Domenico F., Coccia R., Butterfield D. A., Perluigi M., Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues. PLoS ONE 2012 7 3 2-s2.0-84859020443 10.1371/journal.pone.0034366 e34366
207. Gao L., Pan X., Li L., Liang W., Bai P., Rao L., Su X., Wang T., Zhou B., Wei Y., Zhang L., Null genotypes of gstm1 and gstt1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis. PLoS ONE 2011 6 5 2-s2.0-79956344946 10.1371/journal.pone.0020157 e20157
208. Safaeian M., Hildesheim A., Gonzalez P., Yu K., Porras C., Li Q., Rodriguez A. C., Sherman M. E., Schiffman M., Wacholder S., Burk R., Herrero R., Burdette L., Chanock S. J., Wang S. S., Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer. PLoS ONE 2012 7 4 2-s2.0-84859509236 10.1371/journal.pone.0033619 e33619
209. Strzelczyk J. K., Wielkoszyński T., Krakowczyk Ł., The activity of antioxidant enzymes in colorectal adenocarcinoma and corresponding normal mucosa. Acta Biochimica Polonica 2012 59 4 549 556
210. Scarpa M., Cardin R., Bortolami M., Mucosal immune environment in colonic carcinogenesis: CD80 expression is associated to oxidative DNA damage and TLR4-NF B signalling. European Journal of Cancer 2013 49 1 254 263
211. Thyagarajan B., Wang R., Barcelo H., Mitochondrial copy number is associated with colorectal cancer risk. Cancer Epidemiology, Biomarkers and Prevention 2012 21 9 1574 1581
212. Pejić S., Todorović A., Stojiljković V., Antioxidant enzymes and lipid peroxidation in endometrium of patients with polyps, myoma, hyperplasia and adenocarcinoma. Reproductive Biology and Endocrinology 2009 7 article 149
213. Cormio A., Guerra F., Cormio G., Pesce V., Fracasso F., Loizzi V., Cantatore P., Selvaggi L., Gadaleta M. N., The PGC-1 α -dependent pathway of mitochondrial biogenesis is upregulated in type I endometrial cancer. Biochemical and Biophysical Research Communications 2009 390 4 1182 1185 2-s2.0-70450278746 10.1016/j.bbrc.2009.10.114
214. Guerra F., Kurelac I., Cormio A., Zuntini R., Amato L. B., Ceccarelli C., Santini D., Cormio G., Fracasso F., Selvaggi L., Resta L., Attimonelli M., Gadaleta M. N., Gasparre G., Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma. Human Molecular Genetics 2011 20 12 2394 2405 2-s2.0-79957525799 10.1093/hmg/ddr146
215. Ni J., Mei M., Sun L., Oxidative DNA damage and repair in chronic atrophic gastritis and gastric cancer. Hepato-Gastroenterology 2012 59 115 671 675 2-s2.0-84860516682 10.5754/hge12177
216. Uehara T., Ma D., Yao Y., H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer. Digestive Diseases and Sciences 2013 58 1 140 149
217. Machado A. M., Desler C., Bøggild S., Helicobacter pylori infection affects mitochondrial function and DNA repair, thus, mediating genetic instability in gastric cells. Mechanisms of Ageing and Development 2013 134 10 460 466
218. Suzuki Y., Imai K., Takai K., Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test. The Journal of Cancer Research and Clinical Oncology 2013 139 5 845 852
219. Tanaka S., Miyanishi K., Kobune M., Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Journal of Gastroenterology 2013 48 11 1249 1258
220. Tamai T., Uto H., Takami Y., Oda K., Saishoji A., Hashiguchi M., Kumagai K., Kure T., Mawatari S., Moriuchi A., Oketani M., Ido A., Tsubouchi H., Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma. World Journal of Gastroenterology 2011 17 44 4890 4898 2-s2.0-83155177153 10.3748/wjg.v17.i44. 4890
221. Jin Y., Yu Q., Zhou D., The mitochondrial DNA 9-bp deletion polymorphism is a risk factor for hepatocellular carcinoma in the Chinese population. Genetic Testing and Molecular Biomarkers 2012 16 5 330 334
222. Duan W., Hua R., Yi W., Shen L., Jin Z., Zhao Y., Yi D., Chen W., Yu S., The association between OGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis of 27 studies. PLoS ONE 2012 7 4 2-s2.0-84859967026 10.1371/journal.pone.0035970 e35970
223. Cobanoglu U., Demir H., Cebi A., Sayir F., Alp H. H., Akan Z., Gur T., Bakan E., Lipid peroxidation, DNA damage and coenzyme Q(10) in lung cancer patients-markers for risk assessment? Asian Pacific Journal of Cancer Prevention 2011 12 6 1399 1403 2-s2.0-84858046465
224. Janik J., Swoboda M., Janowska B., Cieśla J. M., Gackowski D., Kowalewski J., Olinski R., Tudek B., Speina E., 8-Oxoguanine incision activity is impaired in lung tissues of NSCLC patients with the polymorphism of OGG1 and XRCC1 genes. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 2011 709-710 21 31 2-s2.0-79954589566 10.1016/j.mrfmmm.2011.02.009
225. Tsai J. R., Wang H. M., Liu P. L., High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients. Cell Oncology 2012 35 6 461 471
226. Ito K., Yano T., Morodomi Y., Yoshida T., Kohno M., Haro A., Shikada Y., Okamoto T., Maruyama R., Maehara Y., Serum antioxidant capacity and oxidative injury to pulmonary DNA in never-smokers with primary lung cancer. Anticancer Research 2012 32 3 1063 1067 2-s2.0-84858779334
227. Ye X., Li Q., Wang G., Sun F., Huang G., Bian X., Yu S., Qian G., Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells. International Journal of Cancer 2011 129 4 820 831 2-s2.0-79959723691 10.1002/ijc.25944
228. Chae Y. C., Caino M. C., Lisanti S., Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s. Cancer Cell 2012 22 3 331 344
229. Murtas D., Piras F., Minerba L., Ugalde J., Floris C., Maxia C., Demurtas P., Perra M. T., Sirigu P., Nuclear 8-hydroxy-2′-deoxyguanosine as survival biomarker in patients with cutaneous melanoma. Oncology Reports 2010 23 2 329 335 2-s2.0-76649136984 10.3892/or-00000640
230. Ibarrola-Villava M., Peña-Chilet M., Fernandez L. P., Aviles J. A., Mayor M., Martin-Gonzalez M., Gomez-Fernandez C., Casado B., Lazaro P., Lluch A., Benitez J., Lozoya R., Boldo E., Pizarro A., Martinez-Cadenas C., Ribas G., Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibility. European Journal of Cancer 2011 47 17 2618 2625 2-s2.0-80755153643 10.1016/j.ejca.2011.05.011
231. Lin X., Zheng W., Liu J., Oxidative stress in malignant melanoma enhances Tumor Necrosis Factor- α secretion of tumor-associated macrophages that promote cancer cell invasion. Antioxidants and Redox Signaling 2013 19 12 1337 1355
232. Barbi de Moura M., Vincent G., Fayewicz S. L., Mitochondrial respiration-an important therapeutic target in melanoma. PLoS ONE 2012 7 8 e40690
233. Singh R. K., Tripathi A. K., Tripathi P., Singh S., Singh R., Ahmad R., Studies on biomarkers for oxidative stress in patients with chronic myeloid leukemia. Hematology/Oncology and Stem Cell Therapy 2009 2 1 285 288 2-s2.0-77953660479
234. Sailaja K., Surekha D., Nageswara Rao D., Raghunadha Rao D., Vishnupriya S., Association of the GSTP1 gene (Ile105Val) Polymorphism with chronic myeloid leukemia. Asian Pacific Journal of Cancer Prevention 2010 11 2 461 464 2-s2.0-78650693959
235. Ahmad R., Tripathi A. K., Tripathi P., Singh R., Singh S., Singh R. K., Studies on lipid peroxidation and non-enzymatic antioxidant status as indices of oxidative stress in patients with chronic myeloid leukaemia. Singapore Medical Journal 2010 51 2 110 115 2-s2.0-77951290573
236. Zhou F., Zhang W., Wei Y., Meng S., Bai G., Wang B., Yang H., Tian W., Meng X., Zhang H., Chen S., Involvement of oxidative stress in the relapse of acute myeloid leukemia. The Journal of Biological Chemistry 2010 285 20 15010 15015 2-s2.0-77952049313 10.1074/jbc.M110.103713
237. Palande K. K., Beekman R., van der Meeren L. E., Berna Beverloo H., Valk P. J. M., Touw I. P., The antioxidant protein peroxiredoxin 4 is epigenetically down regulated in acute promyelocytic leukemia. PLoS ONE 2011 6 1 2-s2.0-79251629982 10.1371/journal.pone.0016340 e16340
238. Akinlolu A., Akingbola T., Salau B., Lipid peroxidation in Nigerians affected with haematological malignancies. African Journal of Medicine and Medical Sciences 2012 41 supplement 145 148
239. Boultwood J., Fidler C., Mills K. I., Frodsham P. M., Kusec R., Gaiger A., Gale R. E., Linch D. C., Littlewood T. J., Moss P. A. H., Wainscoat J. S., Amplification of mitochondrial DNA in acute myeloid leukaemia. British Journal of Haematology 1996 95 2 426 431 2-s2.0-10244256349 (Pubitemid 26360237)
240. Koistinen P., Ruuska S., Säily M., Kakko S., Siitonen P., Siitonen T., Savolainen M. J., Kinnula V. L., Savolainen E., An association between manganese superoxide dismutase polymorphism and outcome of chemotherapy in acute myeloid leukemia. Haematologica 2006 91 6 829 832 2-s2.0-33745749337 (Pubitemid 44014554)
241. Schildgen V., Wulfert M., Gattermann N., Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes. Experimental Hematology 2011 39 6 666.e1 675.e1 2-s2.0-79956266039 10.1016/j.exphem.2011.03.007
242. Gokul S., Patil V. S., Jailkhani R., Hallikeri K., Kattappagari K. K., Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. Oral Diseases 2010 16 1 29 33 2-s2.0-73649143850 10.1111/j.1601-0825.2009.01598.x
243. Korde S. D., Basak A., Chaudhary M., Goyal M., Vagga A., Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma. Oncology 2011 80 5-6 382 389 2-s2.0-79961125772 10.1159/000329811
244. Marakala V., Malathi M., Shivashankara A. R., Lipid peroxidation and antioxidant vitamin status in oral cavity and oropharyngeal cancer patients. Asian Pacific Organization for Cancer Prevention 2012 13 11 5763 5765
245. Vlková B., Stanko P., Minárik G., Salivary markers of oxidative stress in patients with oral premalignant lesions. Archives of Oral Biology 2012 57 12 1651 1656
246. Liu S., Jiang R., Chen F., Wang W., Lin J., Somatic mutations in the D-loop of mitochondrial DNA in oral squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology 2012 269 6 1665 1670 2-s2.0-80054695760 10.1007/s00405-011-1806-5
247. Gasparre G., Porcelli A. M., Bonora E., Pennisi L. F., Toller M., Iommarini L., Ghelli A., Moretti M., Betts C. M., Martinelli G. N., Ceroni A. R., Curcio F., Carelli V., Rugolo M., Tallini G., Romeo G., Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors. Proceedings of the National Academy of Sciences of the United States of America 2007 104 21 9001 9006 2-s2.0-34547480470 10.1073/pnas.0703056104 (Pubitemid 47175426)
248. Bonora E., Porcelli A. M., Gasparre G., Biondi A., Ghelli A., Carelli V., Baracca A., Tallini G., Martinuzzi A., Lenaz G., Rugolo M., Romeo G., Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. Cancer Research 2006 66 12 6087 6096 2-s2.0-33745700213 10.1158/0008-5472.CAN-06-0171
249. Sciascia S., Roccatello D., Bertero M. T., 8-isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. Inflammation Research 2012 61 8 809 816
250. Perez-Sanchez C., Ruiz-Limon P., Aguirre M. A., Mitochondrial dysfunction
251. Naziroǧlu M., Kökçam I., Simşek H., Lipid peroxidation and antioxidants in plasma and red blood cells from patients with pemphigus vulgaris. Journal of Basic and Cinical Physiology and Pharmacology 2003 14 1 31 42 (Pubitemid 37236589)
252. Abida O., Ben Mansour R., Gargouri B., Catalase and lipid peroxidation values in serum of Tunisian patients with pemphigus vulgaris and foliaceus. Biological Trace Element Research 2012 150 1-3 74 80
253. Marchenko S., Chernyavsky A. I., Arredondo J., Gindi V., Grando S. A., Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology. The Journal of Biological Chemistry 2010 285 6 3695 3704 2-s2.0-77950472606 10.1074/jbc.M109.081570
254. Kalantari-Dehaghi M., Chen Y., Deng W., Mechanisms of mitochondrial damage in keratinocytes by pemphigus vulgaris antibodies. The Journal of Biological Chemistry 2013 288 23 16916 16925
255. Cash W. J., McCance D. R., Young I. S., McEneny J., Cadden I. S., McDougall N. I., Callender M. E., Primary biliary cirrhosis is associated with oxidative stress and endothelial dysfunction but not increased cardiovascular risk. Hepatology Research 2010 40 11 1098 1106 2-s2.0-77958580365 10.1111/j.1872-034X.2010.00717.x
256. Sorrentino P., Terracciano L., D'Angelo S., Ferbo U., Bracigliano A., Tarantino L., Perrella A., Perrella O., de Chiara G., Panico L., de Stefano N., Lepore M., Vecchione R., Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis. Journal of Gastroenterology 2010 45 10 1053 1062 2-s2.0-78249232939 10.1007/s00535-010-0249-x
257. Salunga T. L., Cui Z., Shimoda S., Zheng H., Nomoto K., Kondo T., Takano Y., Selmi C., Alpini G., Gershwin M. E., Tsuneyama K., Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis. Journal of Autoimmunity 2007 29 2-3 78 86 2-s2.0-34548527467 10.1016/j.jaut.2007.04.002 (Pubitemid 47385107)
258. Leung P. S. C., Rossaro L., Davis P. A., Park O., Tanaka A., Kikuchi K., Miyakawa H., Norman G. L., Lee W., Gershwin M. E., Lee W. M., Polson J., Pezzia C., Larson A., Davern T., Martin P., McCashland T., Hay J. E., Murray N., Shakil A. O., Blei A., Zaman A., Han S., Fontana R., McGuire B., Chung R., Smith A., Schilsky M., Reuben A., Munoz S., Reddy R., Stravitz R. T., Satyanarayana R., Hassanein T., Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology 2007 46 5 1436 1442 2-s2.0-36348950863 10.1002/hep.21828 (Pubitemid 350155525)
259. Basavaraj K. H., Vasu Devaraju P., Rao K. S., Studies on serum 8-hydroxy guanosine (8-OHdG) as reliable biomarker for psoriasis. Journal of the European Academy of Dermatology and Venereology 2013 27 5 655 657 2-s2.0-84855747392 10.1111/j.1468-3083.2011.04441.x
260. Kaur S., Zilmer K., Leping V., Serum methylglyoxal level and its association with oxidative stress and disease severity in patients with psoriasis. Archives of Dermatological Research 2013 305 6 489 494
261. Barygina V. V., Becatti M., Soldi G., Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF- α therapy. Redox Reports 2013 18 3 100 106
262. Gabr S. A., Al-Ghadir A. H., Role of cellular oxidative stress and cytochrome c in the pathogenesis of psoriasis. Archives of Dermatological Research 2012 304 6 451 457 2-s2.0-84858029018 10.1007/s00403-012-1230-8
263. Stark K., Törmä H., Oliw E. H., Co-localization of COX-2, CYP4F8, and mPGES-1 in epidermis with prominent expression of CYP4F8 mRNA in psoriatic lesions. Prostaglandins and Other Lipid Mediators 2006 79 1-2 114 125 2-s2.0-33644558369 10.1016/j.prostaglandins.2005.12.003
264. Shah D., Wanchu A., Bhatnagar A., Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Immunobiology 2011 216 9 1010 1017 2-s2.0-79960844662 10.1016/j.imbio.2011.04.001
265. Connor A. M., Mahomed N., Gandhi R., Keystone E. C., Berger S. A., TNF α modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts. Arthritis Research and Therapy 2012 14 2, article R62 2-s2.0-84860516885 10.1186/ar3778
266. Stamp L. K., Khalilova I., Tarr J. M., Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatology 2012 51 10 1796 1803
267. Kundu S., Ghosh P., Datta S., Oxidative stress as a potential biomarker for determining disease activity in patients with rheumatoid arthritis. Free Radical Research 2012 46 12 1482 1489
268. Ahmad S., Habib S., Moinuddin A., Preferential recognition of epitopes on AGE-IgG by the autoantibodies in rheumatoid arthritis patients. Human Immunology 2013 74 1 23 27
269. Harty L. C., Biniecka M., O'Sullivan J., Fox E., Mulhall K., Veale D. J., Fearon U., Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis. Annals of the Rheumatic Diseases 2012 71 4 582 588 2-s2.0-84857918542 10.1136/annrheumdis-2011-200245
270. Norheim K. B., Jonsson G., Harboe E., Hanasand M., Gøransson L., Omdal R., Oxidative stress, as measured by protein oxidation, is increased in primary Sjøgren's syndrome. Free Radical Research 2012 46 2 141 146 2-s2.0-84856305271 10.3109/10715762.2011.645206
271. Cay H. F., Sezer I., Dogan S., Polymorphism in the TNF- α gene promoter at position -1031 is associated with increased circulating levels of TNF- α myeloperoxidase and nitrotyrosine in primary Sjögren's Syndrome. Clinical and Experimental Rheumatology 2012 30 6 843 849
272. Ryo K., Yamada H., Nakagawa Y., Tai Y., Obara K., Inoue H., Mishima K., Saito I., Possible involvement of oxidative stress in salivary gland of patients with Sjögren's syndrome. Pathobiology 2007 73 5 252 260 2-s2.0-33847416556 10.1159/000098211
273. Kurimoto C., Kawano S., Tsuji G., Hatachi S., Jikimoto T., Sugiyama D., Kasagi S., Komori T., Nakamura H., Yodoi J., Kumagai S., Thioredoxin may exert a protective effect against tissue damage caused by oxidative stress in salivary glands of patients with Sjögren's syndrome. The Journal of Rheumatology 2007 34 10 2035 2043 2-s2.0-35148851645 (Pubitemid 47548207)
274. Ikuno N., Mackay I. R., Jois J., Omagari K., Rowley M. J., Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis. Journal of Gastroenterology and Hepatology 2001 16 12 1390 1394 2-s2.0-0035702469 10.1046/j.1440-1746.2001.02624.x (Pubitemid 34107408)
275. Fernandez D., Bonilla E., Phillips P., Perl A., Signaling abnormalities in systemic lupus erythematosus as potential drug targets. Endocrine, Metabolic and Immune Disorders-Drug Targets 2006 6 4 305 311 2-s2.0-33845609529 (Pubitemid 44941918)
276. Perl A., Hanczko R., Doherty E., Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods in Molecular Biology 2012 900 61 89
277. Hassan I., Sajad P., Majid S., Serum antioxidant status in patients with systemic sclerosis. Indian Journal of Dermatology 2013 58 3 239
278. Zalewska A., Knaś M., Gińdzieńska-Sieśkiewicz E., Salivary antioxidants in patients with systemic sclerosis. Journal of Oral Pathology and Medicine 2013 43 1 61 68 10.1111/jop.12084
279. Cruz-Domínguez M. P., Montes-Cortes D. H., Olivares-Corichi I. M., Oxidative stress in Mexicans with diffuse cutaneous systemic sclerosis. Rheumatology International 2013 33 9 2261 2267
280. Ohtsuka T., Relation between elevated high-sensitivity C-reactive protein and anti-mitochondria antibody in patients with systemic sclerosis. Journal of Dermatology 2008 35 2 70 75 2-s2.0-38949172371 10.1111/j.1346-8138.2008.00418.x (Pubitemid 351229596)
281. Kostyuk V. A., Potapovich A. I., Cesareo E., Brescia S., Guerra L., Valacchi G., Pecorelli A., Deeva I. B., Raskovic D., de Luca C., Pastore S., Korkina L. G., Dysfunction of glutathione S-transferase leads to excess 4-hydroxy-2-nonenal and H(2)O(2) and impaired cytokine pattern in cultured keratinocytes and blood of vitiligo patients. Antioxidants and Redox Signaling 2010 13 5 607 620 2-s2.0-77953494073 10.1089/ars.2009.2976
282. Bassiouny D. A., Khorshied M. M., Glutathione S-transferase M1 and T1 genetic polymorphism in Egyptian patients with nonsegmental vitiligo. Clinical and Experimental Dermatology 2013 38 2 160 163
283. Dell'Anna M. L., Ottaviani M., Bellei B., Albanesi V., Cossarizza A., Rossi L., Picardo M., Membrane lipid defects are responsible for the generation of reactive oxygen species in peripheral blood mononuclear cells from vitiligo patients. Journal of Cellular Physiology 2010 223 1 187 193 2-s2.0-75749111676 10.1002/jcp.22027
284. Heydari B., Kazemi T., Zarban A., Correlation of cataract with serum lipids, glucose and antioxidant activities: a case-control study. West Indian Medical Journal 2012 61 3 230 234
285. Kisic B., Miric D., Zoric L., Ilic A., Dragojevic I., Antioxidant capacity of lenses with age-related cataract. Oxidative Medicine and Cellular Longevity 2012 2012 8 2-s2.0-84858311432 10.1155/2012/467130 467130
286. Zhang Y., Zhang L., Sun D., Li Z., Wang L., Liu P., Genetic polymorphisms of superoxide dismutases, catalase, and glutathione peroxidase in age-related cataract. Molecular Vision 2011 17 2325 2332 2-s2.0-80053037855
287. Jarrett S. G., Lewin A. S., Boulton M. E., The importance of Mitochondria in age-related and inherited eye disorders. Ophthalmic Research 2010 44 3 179 190 2-s2.0-77956571785 10.1159/000316480
288. Lee W., Wells T., Kantorow M., Localization and H(2)O(2)-specific induction of PRDX3 in the eye lens. Molecular Vision 2007 13 1469 1474 2-s2.0-34548346897 (Pubitemid 47335482)
289. Bagis S., Tamer L., Sahin G., Bilgin R., Guler H., Ercan B., Erdogan C., Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatology International 2005 25 3 188 190 2-s2.0-17744364057 10.1007/s00296-003-0427-8 (Pubitemid 40576783)
290. Altindag O., Celik H., Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Report 2006 11 3 131 135 2-s2.0-33746364521 10.1179/135100006X116628 (Pubitemid 44111109)
291. Cordero M. D., Alcocer-Gómez E., Cano-García F. J., de Miguel M., Carrión A. M., Navas P., Alcázar J. A., Clinical symptoms in Fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma. PLoS ONE 2011 6 10 2-s2.0-80055025806 10.1371/journal.pone.0026915 e26915
292. Cordero M. D., de Miguel M., Moreno Fernández A. M., Carmona López I. M., Garrido Maraver J., Cotán D., Gómez Izquierdo L., Bonal P., Campa F., Bullon P., Navas P., Sánchez Alcázar J. A., Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the disease. Arthritis Research and Therapy 2010 12 1, article R17 2-s2.0-77649282583 10.1186/ar2918
293. Cordero M. D., Díaz-Parrado E., Carrión A. M., Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia? Antioxidants and Redox Signaling 2013 18 7 800 807
294. Običan S., Scialli A. R., Teratogenic exposures. American Journal of Medical Genetics C: Seminars in Medical Genetics 2011 157 3 150 169 2-s2.0-79960561020 10.1002/ajmg.c.30310
295. Wells P. G., Bhuller Y., Chen C. S., Jeng W., Kasapinovic S., Kennedy J. C., Kim P. M., Laposa R. R., McCallum G. P., Nicol C. J., Parman T., Wiley M. J., Wong A. W., Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species. Toxicology and Applied Pharmacology 2005 207 2, supplement S354 S366 2-s2.0-24644492970 10.1016/j.taap.2005.01.061 (Pubitemid 41265535)
296. Kovacic P., Somanathan R., Mechanism of teratogenesis: electron transfer, reactive oxygen species, and antioxidants. Birth Defects Research C-Embryo Today: Reviews 2006 78 4 308 325 2-s2.0-33847633507 10.1002/bdrc.20081 (Pubitemid 46365294)
297. Zheng X., Su M., Pei L., Zhang T., Ma X., Qiu Y., Xia H., Wang F., Zheng X., Gu X., Song X., Li X., Qi X., Chen G., Bao Y., Chen T., Chi Y., Zhao A., Jia W., Metabolic signature of pregnant women with neural tube defects in offspring. Journal of Proteome Research 2011 10 10 4845 4854 2-s2.0-80053920356 10.1021/pr200666d
298. Dong J., Sulik K. K., Chen S., The role of NOX enzymes in ethanol-induced oxidative stress and apoptosis in mouse embryos. Toxicology Letters 2010 193 1 94 100 2-s2.0-75749109685 10.1016/j.toxlet.2009.12.012
299. Fantel A. G., Person R. E., Involvement of mitochondria and other free radical sources in normal and abnormal fetal development. Annals of the New York Academy of Sciences 2002 959 424 433 2-s2.0-0036234712 (Pubitemid 34457581)
300. Xu Y., Liu P., Li Y., Impaired development of mitochondria plays a role in the central nervous system defects of fetal alcohol syndrome. Birth Defects Research A-Clinical and Molecular Teratology 2005 73 2 83 91 2-s2.0-14244249501 10.1002/bdra.20110 (Pubitemid 40289532)
301. Harman D., Aging: a theory based on free radical and radiation chemistry. The Journal of Gerontology 1956 11 3 298 300 2-s2.0-77049308856
302. Harman D., Free radical theory of aging: dietary implications. The American Journal of Clinical Nutrition 1972 25 8 839 843 2-s2.0-0015383617
303. Przyklenk K., Kloner R. A., Effect of oxygen-derived free radical scavengers on infarct size following six hours of permanent coronary artery occlusion: salvage or delay of myocyte necrosis? Basic Research in Cardiology 1987 82 2 146 158 2-s2.0-0023178955 (Pubitemid 17069886)
304. Wolff S. P., Bascal Z. A., Hunt J. V., 'Autoxidative glycosylation': free radicals and glycation theory. Progress in Clinical and Biological Research 1989 304 259 275 2-s2.0-0024306417
305. Clausen J., Demential syndromes and the lipid metabolism. Acta Neurologica Scandinavica 1984 70 5 345 355 2-s2.0-0021163865 (Pubitemid 14023099)
306. Zemlan F. P., Thienhaus O. J., Bosmann H. B., Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation. Brain Research 1989 476 1 160 162 2-s2.0-0024490143 (Pubitemid 19006378)
307. Vives-Bauza C., Przedborski S., Mitophagy: the latest problem for Parkinson's disease. Trends in Molecular Medicine 2011 17 3 158 165 2-s2.0-79952451427 10.1016/j.molmed.2010.11.002
308. Wołyniec E., Karpińska J., Losiewska S., Determination of lipoic acid by flow-injection and high-performance liquid chromatography with chemiluminescence detection. Talanta 2012 96 223 229
309. Pagano G., Castello G., Oxidative stress and mitochondrial dysfunction in down syndrome. Advances in Experimental Medicine and Biology 2012 724 291 299 2-s2.0-84859508314 10.1007/978-1-4614-0653-2-22
310. Liu J., The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview. Neurochemical Research 2008 33 1 194 203 (Pubitemid 350242787)
311. Tarnopolsky M. A., The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies. Advanced Drug Delivery Reviews 2008 60 13-14 1561 1567 2-s2.0-51249120293 10.1016/j.addr.2008.05.001
312. McMackin C. J., Widlansky M. E., Hamburg N. M., Huang A. L., Weller S., Holbrook M., Gokce N., Hagen T. M., Keaney J. F. Jr., Vita J. A., Effect of combined treatment with alpha-Lipoic acid and acetyl-L-carnitine on vascular function and blood pressure in patients with coronary artery disease. Journal of Clinical Hypertension 2007 9 4 249 255 2-s2.0-34447342145
313. Parikh S., Goldstein A., Koenig M. K., Practice patterns of mitochondrial disease physicians in North America, part 2: treatment, care and management. Mitochondrion 2013 13 6 681 687
314. Pagano G., Aiello Talamanca A., Castello G., Mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: current experience and rational design of chemoprevention trials. Submitted